V67A Stock Overview
Provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Cosmos Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.05 |
| 52 Week High | US$3.03 |
| 52 Week Low | US$0.45 |
| Beta | 3.02 |
| 11 Month Change | 57.10% |
| 3 Month Change | 62.69% |
| 1 Year Change | -61.78% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -94.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| V67A | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 59.0% | -0.3% | 0.8% |
| 1Y | -61.8% | -0.9% | 2.0% |
Return vs Industry: V67A underperformed the German Healthcare industry which returned 0.8% over the past year.
Return vs Market: V67A underperformed the German Market which returned 3.1% over the past year.
Price Volatility
| V67A volatility | |
|---|---|
| V67A Average Weekly Movement | 25.0% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: V67A's share price has been volatile over the past 3 months.
Volatility Over Time: V67A's weekly volatility has increased from 18% to 25% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 102 | Greg Siokas | www.cosmosholdingsinc.com |
Cosmos Health Inc. provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.
Cosmos Health Inc. Fundamentals Summary
| V67A fundamental statistics | |
|---|---|
| Market cap | €10.68m |
| Earnings (TTM) | -€40.06m |
| Revenue (TTM) | €46.29m |
0.4x
P/S Ratio-0.4x
P/E RatioIs V67A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| V67A income statement (TTM) | |
|---|---|
| Revenue | US$49.59m |
| Cost of Revenue | US$46.03m |
| Gross Profit | US$3.55m |
| Other Expenses | US$46.46m |
| Earnings | -US$42.91m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.55 |
| Gross Margin | 7.17% |
| Net Profit Margin | -86.53% |
| Debt/Equity Ratio | 21.5% |
How did V67A perform over the long term?
See historical performance and comparison